Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon CancerChristine Ribic, Steven Gallinger, Pierre Laurent‐Puig et al.|New England Journal of Medicine|2003Cited by 2.1k
Celecoxib for the Prevention of Sporadic Colorectal AdenomasMonica M. Bertagnolli, Ernest T. Hawk, Craig Eagle et al.|New England Journal of Medicine|2006Cited by 1k
Both p16 <sup>Ink4a</sup> and the p19 <sup>Arf</sup> -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseNabeel Bardeesy, Ronald A. DePinho, Andrew J. Aguirre et al.|Proceedings of the National Academy of Sciences|2006Cited by 585
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib TrialMonica M. Bertagnolli, Craig Eagle, Ann G. Zauber et al.|Cancer Prevention Research|2009Cited by 193